ORIC Q1 2026 Earnings Narrower Loss Misses Estimates as Clinical Development Continues Mereo BioPharma Group plc MREO Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uplift MAPS Q1 2026 Earnings EPS Miss Weighs on Shares Despite Narrow Profit TCPC Q1 2026 Earnings EPS Beats Estimates by Over 10 NU Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Reaction SHF Holdings Inc SHFS Q3 2024 Earnings Modest Profitability Amid Cannabis Financial Services Landscape